Fructose Effect on Neuroinflammation and Feelings
MOODYFRUCTOSE
1 other identifier
interventional
56
1 country
1
Brief Summary
Fructose is increasingly present in our food. The increase in its consumption is associated with the increase in the prevalence of several pathologies such as metabolic syndrome or hepatic steatosis. The effect of fructose consumption on brain health has been poorly studied. Studies in animal models show that diets enriched in fructose promote the development of emotional behavior disorders. Fructose malabsorption is also associated with changes in the microbiota that could also impact brain health. However, no human study to date has associated fructose malabsorption with changes in the gut microbiota and effects on brain health. The objective of this study is to study the emotional behavior of a population of healthy volunteers according to the presence or not of fructose malabsorption. Patients with fructose malabsorption are susceptible to gut dysbiosis without necessarily consuming high amounts of fructose.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 8, 2021
CompletedFirst Submitted
Initial submission to the registry
January 3, 2022
CompletedFirst Posted
Study publicly available on registry
May 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 16, 2022
CompletedMay 18, 2026
February 1, 2026
11 months
January 3, 2022
May 13, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluate the chronic effect of fructose on anxiety in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.
Spielberger State Anxiety Questionnaire Score (STAI) with 20 items rated from 1(none) to 4 (a lot).
Day 1
Secondary Outcomes (4)
Evaluate the fructose consumption in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.
For 7 days before day 30
Evaluate the chronic effect of fructose on depression in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.
Day 1
Evaluate the chronic effect of fructose on low-grade intestinal inflammation in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.
up to 1 month
Evaluate the chronic effect of fructose on microbiota's composition in healthy volunteers with fructose malabsorption compared to healthy volunteers without fructose malabsorption.
up to 1 month
Study Arms (1)
Healthy volunteers
OTHERInterventions
Healthy volunteers will performed a fructose respiratory test in order to evaluate if they are or not fructose malabsorbing. The two population will be compared about their feelings and their micriobiote.
Eligibility Criteria
You may qualify if:
- Healthy volunteers
- Aged 18 to 35
- Male sex
- BMI between 18.5 and 25
- Affiliation to a social security scheme
- Adult patient having read and understood the information letter and signed the consent form
You may not qualify if:
- Presence of irritable bowel syndrome, celiac disease
- Presence of a psychiatric illness
- Presence of a neurodegenerative disease
- Presence of an eating disorder
- Presence of chronic disease, including inflammatory disease
- Presence of diabetes
- Presence of an acute infectious disease
- Presence of a surgical history of the digestive tract (excluding appendectomy)
- Taking long-term treatment
- Taking antibiotics within 6 months
- Taking probiotics within 3 months
- Typical diet low in lactose, FODMAP, gluten, vegetarian, vegan, vegan, chromonutrition .... in progress
- Smoker
- Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection / under guardianship or guardianship
- Simultaneous participation in another interventional clinical trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de ROUEN
Rouen, Rouen, 76000, France
Related Publications (1)
Coursan A, Polve D, Leroi AM, Monnoye M, Roussin L, Benatar C, Tavolacci MP, Quillard Muraine M, Maccarone M, Guerin O, Houivet E, Guerin C, Brunel V, Bellenger J, Pais de Barros JP, Gourcerol G, Naudon L, Laye S, Madore C, Fioramonti X, Melchior C, Douard V. Fructose malabsorption induces dysbiosis and increases anxiety in male human and animal models. Brain Behav Immun. 2026 Mar;133:106221. doi: 10.1016/j.bbi.2025.106221. Epub 2025 Dec 17.
PMID: 41418890RESULT
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Chloé Melchior
University Hospital, Rouen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 3, 2022
First Posted
May 12, 2022
Study Start
June 8, 2021
Primary Completion
May 16, 2022
Study Completion
May 16, 2022
Last Updated
May 18, 2026
Record last verified: 2026-02